These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27238053)

  • 1. FDA labeling of NSAIDs: Review of nonsteroidal anti-inflammatory drugs in cardiovascular disease.
    Pirlamarla P; Bond RM
    Trends Cardiovasc Med; 2016 Nov; 26(8):675-680. PubMed ID: 27238053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COX-2 in play at the AHA and the FDA.
    FitzGerald GA
    Trends Pharmacol Sci; 2007 Jul; 28(7):303-7. PubMed ID: 17573128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Safety and Bleeding Risk Associated with Nonsteroidal Anti-Inflammatory Medications in Patients with Cardiovascular Disease.
    Ross SJ; Elgendy IY; Bavry AA
    Curr Cardiol Rep; 2017 Jan; 19(1):8. PubMed ID: 28138824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nonsteroidal anti-inflammatory drugs: cardiovascular, cerebrovascular and renal effects].
    Batlouni M
    Arq Bras Cardiol; 2010 Apr; 94(4):556-63. PubMed ID: 20498929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs.
    Farkouh ME; Greenberg BP
    Am J Cardiol; 2009 May; 103(9):1227-37. PubMed ID: 19406264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk with non-steroidal anti-inflammatory drugs: clinical implications.
    Bello AE; Holt RJ
    Drug Saf; 2014 Nov; 37(11):897-902. PubMed ID: 25079141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular adverse effects of anti-inflammatory drugs.
    Roubille C; Martel-Pelletier J; Davy JM; Haraoui B; Pelletier JP
    Antiinflamm Antiallergy Agents Med Chem; 2013; 12(1):55-67. PubMed ID: 23286294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposed NSAID package insert labeling.
    Food and Drug Administration U.S. Public Health Service
    J Pain Palliat Care Pharmacother; 2006; 20(1):49-55. PubMed ID: 16687359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of nonsteroidal anti-inflammatory drug-induced cardiotoxicity.
    Singh BK; Haque SE; Pillai KK
    Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):143-56. PubMed ID: 24215502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
    Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S
    Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis and recommendations for agency action regarding nonsteroidal antiinflammatory drugs and cardiovascular risk.
    U.S. Food and Drug Administration
    J Pain Palliat Care Pharmacother; 2005; 19(4):83-97. PubMed ID: 16431839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-selective nonsteroidal anti-inflammatory drugs and cardiovascular events: is aldosterone the silent partner in crime?
    Knights KM; Mangoni AA; Miners JO
    Br J Clin Pharmacol; 2006 Jun; 61(6):738-40. PubMed ID: 16722838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.
    Vardeny O; Solomon SD
    Cardiol Clin; 2008 Nov; 26(4):589-601. PubMed ID: 18929233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance.
    Borer JS; Simon LS
    Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S14-22. PubMed ID: 16168077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs.
    Joshi GP; Gertler R; Fricker R
    Anesth Analg; 2007 Dec; 105(6):1793-804, table of contents. PubMed ID: 18042885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular issues of COX-2 inhibitors and NSAIDs.
    Wong M; Chowienczyk P; Kirkham B
    Aust Fam Physician; 2005 Nov; 34(11):945-8. PubMed ID: 16299629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult?
    Barkin RL; Beckerman M; Blum SL; Clark FM; Koh EK; Wu DS
    Drugs Aging; 2010 Oct; 27(10):775-89. PubMed ID: 20883058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of nonsteroidal anti-inflammatory drugs in patients with cardiovascular disease: a cautionary tale.
    Amer M; Bead VR; Bathon J; Blumenthal RS; Edwards DN
    Cardiol Rev; 2010; 18(4):204-12. PubMed ID: 20539104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriate use of NSAIDs: considering cardiovascular risk in the elderly.
    Stillman MJ; Stillman MT
    Geriatrics; 2007 Mar; 62(3):16-21. PubMed ID: 17346094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nonsteroidal antiinflammatory drugs: gastrointestinal and cardiovascular and renal safety].
    Oscanoa-Espinoza T; Lizaraso-Soto F
    Rev Gastroenterol Peru; 2015 Jan; 35(1):63-71. PubMed ID: 25875519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.